Product Images Carvedilol

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 21 images provide visual information about the product associated with Carvedilol NDC 67296-1901 by Redpharm Drug, Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Carvedilol Tablets USP, 12.5 mg - NDC 72888-036-00 - 1000 Tablets Container Label - carvedilol tab usp 12pt5mg 1000s label

Carvedilol Tablets USP, 12.5 mg - NDC 72888-036-00  - 1000 Tablets Container Label - carvedilol tab usp 12pt5mg 1000s label

This text appears to be the information for a medication called carvedilol. Each tablet contains 12.5mg of carvedilol and is identified by the National Drug Code (NDC) 72888-036-00. The tablets should be stored below 30°C (86°F) and protected from moisture. It is important not to accept the medication if the seal under the cap is missing or broken. The tablets should be dispensed in a tight, light-resistant container. The quantity of tablets in the container is 1000. The dosage instructions can be found in the accompanying prescribing information. The text also includes details about the manufacturer and distributor of the medication, with the manufacturer being Rubicon Research Private Limited in India and the distributor being Advagen Pharma Limited in the USA. The manufacturing license number is KD-682 21145. Lastly, there is mention of an overprinting area with dimensions of 55 mm x 20 mm.*

Carvedilol Tablets USP, 12.5 mg - NDC 72888-036-01 - 100 Tablets Container Label - carvedilol tab usp 12pt5mg 100s label

Carvedilol Tablets USP, 12.5 mg - NDC 72888-036-01  - 100 Tablets Container Label - carvedilol tab usp 12pt5mg 100s label

Each tablet contains 12.5mg of carvedilol. The tablets should be dispensed in a tight, light-resistant container. They are distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited. The tablets should be stored below 30°C (86°F) and protected from moisture. The dosage instructions are mentioned in the accompanying prescribing information. The tablets are marked as USP Mg L No K082 2 and there should be no acceptance if the seal under the cap is missing or broken. The overprinting indicates that there are 100 tablets in the container. The prescription for these tablets is restricted and they are only available with a prescription.*

Carvedilol Tablets USP, 12.5 mg - NDC 72888-036-30 - 30 Tablets Container Label - carvedilol tab usp 12pt5mg 30s label

Carvedilol Tablets USP, 12.5 mg - NDC 72888-036-30  - 30 Tablets Container Label - carvedilol tab usp 12pt5mg 30s label

Carvedilol Tablets USP, 12.5 mg - NDC 72888-036-05 - 500 Tablets Container Label - carvedilol tab usp 12pt5mg 500s label

Carvedilol Tablets USP, 12.5 mg - NDC 72888-036-05  - 500 Tablets Container Label - carvedilol tab usp 12pt5mg 500s label

Each tablet contains carvedilol, a medication used to treat high blood pressure and heart failure. The tablets contain 12.5mg of the active ingredient. The tablets should be stored below 30°C (86°F) and protected from moisture. It is important not to accept the medication if the seal under the cap is missing or broken. The tablets should be dispensed in a tight, light-resistant container. This particular package contains 500 tablets and is available by prescription only. Detailed dosage instructions can be found in the accompanying prescribing information. The medication is distributed by Advagen Pharma Limited, located at 666 Plainsboro Road Suite 605, Plainsboro, NJ, 08536, USA. It is manufactured by Rubicon Research Private Limited in Ambernath, Dist. Thane, India.*

Carvedilol Tablets USP, 25 mg - NDC 72888-037-00 - 1000 Tablets Container Label - carvedilol tab usp 25mg 1000s label

Carvedilol Tablets USP, 25 mg - NDC 72888-037-00  - 1000 Tablets Container Label - carvedilol tab usp 25mg 1000s label

Carvedilol Tablets USP, 25 mg - NDC 72888-037-01 - 100 Tablets Container Label - carvedilol tab usp 25mg 100s label

Carvedilol Tablets USP, 25 mg - NDC 72888-037-01  - 100 Tablets Container Label - carvedilol tab usp 25mg 100s label

This is a description of a medication labeled as carvedilol. Each tablet contains 25 mg of carvedilol. The medication is stored below 30°C (86°F) and should be protected from moisture. It is advised not to accept the medication if the seal under the cap is missing or broken. The tablets should be dispensed in a tightly sealed and light-resistant container. The package contains 100 tablets and it is only available with a prescription. Specific dosage instructions can be found in the accompanying prescribing information. The medication is distributed by Advagen Pharma Limited, located at 666 Plainsboro Road Suite 605, Plainsboro, NJ, 08536, USA. It is manufactured by Rubicon Research Private Limited, located in Ambernath, Dist. Thane, 421506, India. The manufacturing license number is KD-682 21147. The overprinting area on the packaging measures 45 mm x 20 mm.*

Carvedilol Tablets USP, 25 mg - NDC 72888-037-30 - 30 Tablets Container Label - carvedilol tab usp 25mg 30s label

Carvedilol Tablets USP, 25 mg - NDC 72888-037-30  - 30 Tablets Container Label - carvedilol tab usp 25mg 30s label

Carvedilol Tablets USP, 25 mg - NDC 72888-037-05 - 500 Tablets Container Label - carvedilol tab usp 25mg 500s label

Carvedilol Tablets USP, 25 mg - NDC 72888-037-05  - 500 Tablets Container Label - carvedilol tab usp 25mg 500s label

Each tablet contains carvedilol, NDC 72888-037-05, with a strength of 25mg. It is recommended to store the tablets below 30°C (86°F) and protect them from moisture. Customers should not accept the product if the seal under the cap is missing or broken. The tablets should be dispensed in a tight, light-resistant container. The package contains 500 tablets and is only available with a prescription. For dosage information, refer to the accompanying prescribing information. The product is distributed by Advagen Pharma Limited, located at 666 Plainsboro Road Suite 605, Plainsboro, NJ, 08536, USA. It is manufactured by Rubicon Research Private Limited in Ambernath, Dist. Thane, 421506, India. The manufacturing license number is KD-682 21148. The overprinting area of the packaging measures 55mm x 20mm.*

Carvedilol Tablets USP, 3.125 mg - NDC 72888-034-00 - 1000 Tablets Container Label - carvedilol tab usp 3pt125mg 1000s label

Carvedilol Tablets USP, 3.125 mg - NDC 72888-034-00  - 1000 Tablets Container Label - carvedilol tab usp 3pt125mg 1000s label

Carvedilol Tablets USP, 3.125 mg - NDC 72888-034-01 - 100 Tablets Container Label - carvedilol tab usp 3pt125mg 100s label

Carvedilol Tablets USP, 3.125 mg - NDC 72888-034-01  - 100 Tablets Container Label - carvedilol tab usp 3pt125mg 100s label

This text appears to be a description of a medication called Carvedilol. Each tablet contains 3.125mg of the active ingredient. The medication is dispensed in a tight, light-resistant container. The distributor is Advagen Pharma Limited, located at 666 Plainsboro Road Suite 605, Plainsboro, NJ, 08536, USA. The manufacturer is Rubicon Research Private Limited, located in Ambernath, Dist. Thane, 421506 India. The tablets should be stored below 30°C (86°F) and protected from moisture. The dosage instructions are not available in the provided text. The text also mentions the need to check the accompanying prescribing information. The medication comes in a pack of 100 tablets and is only available with a prescription.*

Carvedilol Tablets USP, 3.125 mg - NDC 72888-034-30 - 30 Tablets Container Label - carvedilol tab usp 3pt125mg 30s label

Carvedilol Tablets USP, 3.125 mg - NDC 72888-034-30  - 30 Tablets Container Label - carvedilol tab usp 3pt125mg 30s label

Each tablet contains carvedilol. It is dispensed in a tight, light-resistant container. The tablets are manufactured by Rubicon Research Private Limited and distributed by Advagen Pharma Limited. They contain 3.125mg of carvedilol. Store the tablets below 30°C (86°F) and protect them from moisture. The dosage information can be found in the accompanying prescribing information. The tablets are only for prescription use. Do not accept if the seal under the cap is missing or broken. The tablets are identified with the NDC code 72888-034-30 and the USP Mg Lic No. KD-682 21134.*

Carvedilol Tablets USP, 3.125 mg - NDC 72888-034-05 - 500 Tablets Container Label - carvedilol tab usp 3pt125mg 500s label

Carvedilol Tablets USP, 3.125 mg - NDC 72888-034-05  - 500 Tablets Container Label - carvedilol tab usp 3pt125mg 500s label

Description: This text appears to be a label or description for a medication called Carvedilol. Each tablet contains 3.125mg of carvedilol. It is recommended to store the tablets below 30°C (86°F) and protect them from moisture. The medication is distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited. The text also mentions a prescribing information, dosage instructions, and a warning to not accept the product if the seal under the cap is missing or broken. Please note that the quality of the text is low, and some details may be missing or unclear.*

Carvedilol Tablets USP, 6.25 mg - NDC 72888-035-00 - 1000 Tablets Container Label - carvedilol tab usp 6pt25mg 1000s label

Carvedilol Tablets USP, 6.25 mg - NDC 72888-035-00  - 1000 Tablets Container Label - carvedilol tab usp 6pt25mg 1000s label

Each tablet contains 6.25 mg of carvedilol. The tablets should be stored below 30°C (86°F) and protected from moisture. Do not use if the seal under the cap is missing or broken. The tablets should be dispensed in a tight, light-resistant container. The dosage information can be found in the accompanying prescribing information. The product is distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited in India. The NDC number for the product is 72888-035-00.*

Carvedilol Tablets USP, 6.25 mg - NDC 72888-035-01 - 100 Tablets Container Label - carvedilol tab usp 6pt25mg 100s label

Carvedilol Tablets USP, 6.25 mg - NDC 72888-035-01  - 100 Tablets Container Label - carvedilol tab usp 6pt25mg 100s label

Each tablet contains carvedilol, a medication used for the treatment of high blood pressure, heart failure, and certain heart conditions. It is distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited. The tablets come in a 6.25 mg dosage and should be stored below 30°C (86°F) and protected from moisture. The prescribing information is available with the tablets. It is important not to accept if the seal under the cap is missing or broken. The package contains 100 tablets and is intended for prescription use only.*

Carvedilol Tablets USP, 6.25 mg - NDC 72888-035-30 - 30 Tablets Container Label - carvedilol tab usp 6pt25mg 30s label

Carvedilol Tablets USP, 6.25 mg - NDC 72888-035-30  - 30 Tablets Container Label - carvedilol tab usp 6pt25mg 30s label

Carvedilol Tablets USP, 6.25 mg - NDC 72888-035-05 - 500 Tablets Container Label - carvedilol tab usp 6pt25mg 500s label

Carvedilol Tablets USP, 6.25 mg - NDC 72888-035-05  - 500 Tablets Container Label - carvedilol tab usp 6pt25mg 500s label

Each tablet contains 6.25 mg of carvedilol. It should be stored below 30°C (86°F) and protected from moisture. Do not use if the seal under the cap is missing or broken. The tablets should be dispensed in a tight, light-resistant container. The dosage information can be found in the accompanying prescribing information. The product is distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited in India. It comes in a package of 500 tablets.*

Figure 1. Survival Analysis for COPERNICUS (intent-to-treat) - carvedilol tab usp figure1

Figure 1. Survival Analysis for COPERNICUS (intent-to-treat) - carvedilol tab usp figure1

Figure 2. Effects on Mortality for Subgroups in COPERNICUS - carvedilol tab usp figure2

Figure 2. Effects on Mortality for Subgroups in COPERNICUS - carvedilol tab usp figure2

Figure 3. Survival Analysis for CAPRICORN (intent-to-treat) - carvedilol tab usp figure3

Figure 3. Survival Analysis for CAPRICORN (intent-to-treat) - carvedilol tab usp figure3

Figure 4. Effects on Mortality for Subgroups in CAPRICORN - carvedilol tab usp figure4

Figure 4. Effects on Mortality for Subgroups in CAPRICORN - carvedilol tab usp figure4

carvedilol chemical structure - carvedilol tab usp structure

carvedilol chemical structure - carvedilol tab usp structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.